Description: Sotera Health Company, along with its three best-in-class businesses – Sterigenics®, Nordion® and Nelson Labs®, is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. With a combined tenure across our businesses of nearly 200 years and our industry-recognized scientific and technological expertise, we help to ensure the safety of over 190 million patients and healthcare practitioners around the world every year.
Home Page: soterahealth.com
SHC Technical Analysis
9100 South Hills Boulevard
Broadview Heights,
OH
44147
United States
Phone:
440 262 1410
Officers
| Name | Title |
|---|---|
| Mr. Michael B. Petras Jr. | Chairman & CEO |
| Mr. Michael P. Rutz | Pres of Sterigenics |
| Mr. Michael F. Biehl | Interim Chief Financial Officer |
| Mr. Kevin Theriault | Sr. VP of Operations |
| Mr. Robert G. Hauzie | Chief Information Officer |
| Joseph Vitale | VP of Investor Relations |
| Mr. Alexander Dimitrief | Sr. VP & Gen. Counsel |
| Ms. Kristin A. Gibbs | Chief Marketing Officer |
| Mr. William Lehmann Jr., J.D., M.B.A., MBA | Sr. VP of Strategy & Corp. Devel. |
| Ms. Sally R. Turner | Chief HR Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 8.3264 |
|---|---|
| Trailing PE: | 20.093 |
| Price-to-Book MRQ: | 3.9476 |
| Price-to-Sales TTM: | 2.4396 |
| IPO Date: | 2020-11-20 |
| Fiscal Year End: | December |
| Full Time Employees: | 3000 |